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ABSTRACT
Skeletal muscle fiber type composition has not been studied in the long-lived Ames
dwarf mouse when compared to its wild-type counterpart. Hindlimb soleus skeletal
muscle from two 3-month old dwarf and two 3-month old wild-type mice was analyzed
for muscle fiber size, proportion of type I (slow-twitch) and type II (fast-twitch) muscle
fibers, myonuclei content per muscle fiber, and total cross sectional area of the muscle.
Results revealed a significant difference in muscle fiber size (t(58)=-9.71, p<.001) with
the wild-type mice demonstrating significantly larger muscle fibers. Descriptive statistics
reveal a larger proportion of type I muscle fibers in the Ames dwarf mouse when
compared to the wild-type mouse (2:1 ratio of type I to type II muscle fibers in the dwarf
mice, nearly equal ratio in the wild-type mice). Myonuclei content reveals slightly more
nuclei per muscle fiber in the wild-type mouse (1.035 more nuclei per fiber). Crosssectional area analysis reveals that the wild-type mouse has a substantially larger soleus
muscle than the Ames dwarf. The increased proportion of type I fibers in the Ames
dwarf mouse could contribute to the heightened antioxidant defenses previously
discovered in dwarf skeletal muscle. This study has several methodological limitations
including small sample size, inadequate microscopic views, and analysis of only one
muscle and age group of mice. Future studies should include a larger sample size of both
genotypes with specimens of varying ages, and include a larger selection of muscles.
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CHAPTER 1

LITERATURE REVIEW

Sarcopenia is defined as the progressive decline in muscle mass, strength, and
quality that is associated with the normal aging process. The prevalence of this condition
among adult humans under the age of 70 is around 25%, and this number increases to
40% of people over 80 years of age.1 Sarcopenia is a risk factor for frailty, loss of
independence, and physical disability in older adults,2 and as of 2000 it was estimated
that the healthcare costs attributable to sarcopenia in the US were $18.5 billion annually.3
In addition, the costs associated with this condition can be expected to rise significantly
as advances in healthcare prolong the average lifespan. The US Census Bureau reported
a 35% increase in adults over 80 years of age when comparing data between the years
1990 and 2000.4 Due to the ever increasing prevalence of age-related strength loss, much
research has focused on the treatment and prevention of this condition. Numerous
pharmacological treatments such as administration of testosterone, growth hormone
(GH), dehydroepiandrasterone (DHEA), and regulators of myostatin have been studied in
elderly populations. However, these treatments yielded limited success in muscle
hypertrophy and strength gains, and were often associated with high rates of adverse
effects.
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One of the most recognized clinical findings for this population is that resistance training
is the safest and most effective treatment to maintain strength and function.5 Resistance
training has been found to increase protein synthesis leading to muscle hypertrophy
regardless of age,6,7 and it is this muscle hypertrophy that directly combats age-related
sarcopenia.
Along with sarcopenia, the elderly typically demonstrate other age-related
changes. Some of these changes include an increase in the stiffness of collagen
molecules causing decreased elasticity of skin and blood vessels, a decline in the function
of most organs leading to a higher probability of chronic illness and functional
dependency, a decrease in hormone levels, neurological declines leading to altered
cognitive status, and a decrease in the sensations of hearing, sight, taste, smell, and touch.
From a musculoskeletal perspective, along with the aforementioned loss of muscle mass,
the aging adult can expect to see decreases in height, bone density, and cartilage
integrity.8
Several theories have been proposed as to the etiology of both sarcopenia and
aging. The “free radical theory of aging” states that the degenerative changes that
accompany aging can be attributed to the effects of free radicals, or reactive oxygen
species (ROS), on cellular contents such as cell membrane lipids, proteins, and DNA,9 as
well as collagen and the connective tissues of the body.10 These ROS are produced by
normal metabolic processes utilizing oxygen for cellular respiration.10 It has been found
that in mammals, the organs that are most susceptible to oxidative stresses are those that
are postmitotic, which are organs and tissues that no longer undergo cellular
2

reproduction. Some examples of postmitotic organs are the brain, heart, and, of
importance to this study, skeletal muscle.9 The free radical theory has since been
modified into the oxidative stress theory and the mitochondrial theory of aging, based on
the fact that the mitochondria use 85% of the oxygen in the cell and thus are the greatest
source of ROS.11 Considerable research has been conducted on these theories; however,
very few of these studies can definitively identify a link between oxidative damage and
altered energy production and cellular function.9
Other proposed theories of aging include early Darwinesque evolutionary-based
theories such as that proposed by German biologist August Weismann, which states that
aging evolved as an advantage to the species, as opposed to the individual, with the older
organism dying of natural causes leading to increased resources available for the younger
organism.12 Other evolutionary theories include the mutation accumulation theory, which
states that genes are mutated naturally throughout life and that aging is a byproduct of
natural selection,13 and the antagonistic pleiotropy model, which states that certain genes
are beneficial at earlier ages, but cause harm as one ages.14 Other theorists have
postulated numerous factors which determine how an organism ages ranging from
sleep,15 to telomere length,16 to the Hayflick limit theory which proposes that cells can
only reproduce themselves a limited number of times, thus leading to eventual death.17
However, in the midst of all of these proposed theories of aging, the only intervention
that has been consistently supported by research is caloric restriction.18 Restricting
caloric intake has been shown to prolong the lifespan in rodents, Drosophila, rotifers,
some species of spiders, nemotodes (C elegans) and primates, although the mechanisms
behind this continue to be unknown.18 Researchers have used these animal models to
3

predict the effects of caloric restriction on humans and have postulated that if a 48-yearold male were to restrict his caloric intake by 30% until his normal life expectancy of 78
years, he may increase his life expectancy by 2.8 years, but he may also be in a state of
constant hunger for this period of time.19
Sarcopenia has been associated with numerous contributing factors, including
changes in neuronal20 and hormonal status,21 substandard nutrition,22 low-grade chronic
inflammation,23 and physical inactivity.21 One of the key findings regarding sarcopenia
on a cellular level is that age-related muscle atrophy is a combination of both a decrease
in the size of individual muscle fibers, and in the total number of fibers.24,25 Another
finding is that this decrease in muscle fiber size and number is more prevalent in fasttwitch, anaerobic type II muscle fibers24,26 as compared with slow-twitch, aerobic type I
muscle fibers. These changes lead to a decreased amount of specific force and unloaded
shortening velocity of the affected muscles.27,28 Additional micro level factors
contributing to sarcopenia are myonuclear apoptosis,29 decreased efficacy of excitationcontraction coupling,30 structural changes in the contractile proteins myosin and actin
leading to weaker interactions between these proteins,31 a decreased ability of aging
muscle to oxidize fatty acids for energy purposes,32 as well as negative effects of
nitration, carbonylation, and glycation.31
It has been shown previously that the soleus muscle of a rat is composed of
greater than 90% type I fibers, whereas the semimembranosus muscle is composed of
greater than 90% type IIB fibers.33 These same two rat muscles have been shown to
exhibit differing degrees of age-related atrophy, with the semimembranosus
4

demonstrating significant reductions in force generating capacity earlier than the
soleus.34,35,28 This may partially be due to the fact that the semimembranosus muscle
sustains a significant age-associated decrease in myosin content, whereas the soleus does
not.36 It has also been suggested that these muscle fiber types differ in susceptibility to
oxidative damage, as type I fibers have better oxidant defenses.37 However, the soleus
and other type I muscle fibers are not fully immune to the aging process as senescent rats
have been shown to demonstrate significant changes in muscle composition over their
younger counterparts in this muscle.38
The Ames dwarf mouse (df/df) is a standard model for analyzing the mechanisms
involved in the aging process, as this variety of mouse lives an average of 350 to 470
days longer (an increase of 50% and 60%, respectively) than wild-type mice in its male
and female populations, respectively.39 The Ames dwarf mice are approximately onethird the size of their wild-type counterparts (Figure 1) and have a pituitary deficiency
caused by one substituted nucleotide in the Prophet (Pit-1) gene, which causes a
hypoplasia in the anterior pituitary after birth.40 This leads to an absence of, or reduction
in, anterior pituitary cells that produce GH, prolactin (PRL), and thyroid-stimulating
hormone (TSH),41,42 as well as greatly reduced levels of insulin-like growth factor I (IGF1).43 Several elements have been proposed to relate the GH deficiency exhibited in the
Ames dwarf with delayed aging including reduced synthesis of IGF-1, reduced secretion
of insulin, increased sensitivity to insulin actions, reduced plasma glucose, reduced
generation of ROS, improved antioxidant defenses, increased resistance to oxidative
stress, and reduced oxidative damage.44 Specifically relevant to this study is the fact that
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the Ames dwarf skeletal muscle has been shown to demonstrate heightened antioxidant
defenses when compared to wild-type mice in both an active and resting state.45

Figure 1. Relative Size of Ames Dwarf Mouse Compared to Wild-type.
The skeletal muscle architectural and fiber type differences have not yet been
investigated in the Ames dwarf mouse compared to its wild-type counterpart. The
purpose of this study was to determine whether differences exist between Ames dwarf
and wild-type mice in terms of skeletal muscle cell and fiber composition, and whether
those differences might reflect the resistance to aging exhibited by this mammal.
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CHAPTER II
METHODS
Animals and Tissue Extraction
The mice utilized in this study were housed at the Center for Biomedical Research
at the University of North Dakota (UND) and were raised according to standard
laboratory protocol. A protocol for this experiment was reviewed and approved by the
UND Institutional Animal Care and Use Committee. Three-month-old wild-type and
Ames dwarf mice were selected for this study. Female specimens were chosen to
minimize confounding effects of physiological differences between female and male
mice due to hormones and overall size differences. Two mice were chosen for each
genotype and age group based on sample availability and time constraints.
Skeletal muscle extraction from the hindlimb was conducted under general
anesthetic of 250 µl (+ 50 µl) of tribromoethanol injected into the peritoneal cavity. This
method allowed the organism to remain alive and maintain a heartbeat during dissection,
thus allowing the skeletal muscles to receive bloodflow directly up to the point of
extraction. Pain and sensory reflexes were assessed to determine the effectiveness of the
anesthetic via a sharp pinching of the forefoot and test of the corneal reflex before any
dissection was conducted.
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If no pain or corneal reflexes were present (determined by limb withdrawal and
closing the eye, respectively), it was deemed appropriate to begin the dissection.
Additional anesthetic (50 ul) was administered if the mouse demonstrated any of the
aforementioned signs of peripheral sensory integrity during the tissue extraction
procedure. The gastrocnemius, soleus, tibialis anterior, and extensor digitorum longus
(EDL) muscles were identified via the expected muscle actions upon a slight tension
applied to the tendon insertion. They were then isolated, cut at the proximal and distal
ends, extracted, and immediately frozen in isopentane which was cooled by liquid
nitrogen46 to protect the tissue against degradation. These samples were then stored at
-20°C prior to slicing.
To maintain the proper length and orientation of the skeletal muscle, a special
preparation was needed for the smaller soleus and EDL muscles. These muscles were
placed upon a section of liver from a sacrificed mouse which allowed the muscle to retain
its resting length, as these muscles (unlike the gastrocnemius and tibialis anterior) tended
to contract into a shortened state upon extraction. The liver provided an adhesive quality
that prevented the muscle from shortening its length without sacrificing cellular
composition of the skeletal muscle samples. The opposite hindlimb muscles were
dissected, frozen in liquid nitrogen, and then stored at -20°C for future enzymatic
analysis of the skeletal muscle tissue. The animals were sacrificed upon completion of
the dissection via decapitation or by excision of the heart from the chest.
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Tissue Preparation
The skeletal muscle tissues were sliced at a thickness of 10 µm in an orientation
transverse to the long axis of the muscle. The slicing was conducted inside a Microm
HM 550 Cryostat machine (ThermoFisher Scientific, Walldorf, Germany) maintained at a
temperature of -25ºC. These samples were immediately placed upon a gelatinized
microscope slide and were stored at -20ºC. These sliced samples were treated with a
hematoxylin and eosin (H&E) stain to distinguish the nucleus, cytoplasm, and cell
membrane of the muscle tissue. A muscle fiber type stain was then applied to the
samples via the Vector M.O.M. Immunodetection PK-2200 kit procedure (Vector
Laboratories Inc, Burlingame, CA) to isolate and identify the type I and type II muscle
fibers.
Cellular Composition Analysis
Thirty samples were selected from the proximal, midpoint, and distal ends of each
dissected muscle for analysis of cellular composition throughout the full length of the
muscle. One H&E stained sample from each specimen was analyzed for number of total
muscle fibers per area of sample, muscle fiber size, and number of myonuclei per number
of total fibers. The muscle fiber type stained samples were analyzed for number of type I
and type II muscle fibers, respectively. All area measurements were made in the units of
square micrometers.
Quantification was performed by transferring the microscopic view of each
sample into Scion Image Software (Scion Corporation, Frederick, MD) and manually
9

labeling and counting each viable muscle fiber and nucleus for the H&E stained samples
and the number of type of muscle fiber (I and II) for the fiber type stained samples.
Muscle fiber size was also measured for each H&E stained sample. This was done by
first setting the scale on the Scion Image Software program to the correct scale identified
on the sample slides in micrometers. This resulted in a consistent value of 0.981 pixels
per micrometer. The sizing tool of this program was then utilized to find fiber area by
manually tracing each fiber three times and averaging these measurements for a resultant
mean in square micrometers. To ensure accuracy and consistency, each experimenter
measured the area of the muscle after enlarging the view three times. This minimized
error resulting from incorrect cursor movement in the less detailed view.
Statistical Analysis
Due to time constraints this study examined only the soleus muscles in 3 monthold Ames dwarf and normal mice. Statistical analyses were performed on this study
using the SPSS version 17.0 statistical software (SPSS Inc, Chicago, IL). An
independent-measures t-test was chosen for the dependent variable of muscle fiber size
versus the independent variable of genotype. The small number of samples utilized in
this study yielded a very limited power calculation, thus, the decision was made to treat
the dependent variable of muscle fiber size as separate muscle fiber means instead of an
overall mean of all muscle fibers in the sample. This allowed our muscle fiber size
sample to increase from a number of four (N=4) to a number of sixty (N=60). This was
accomplished by randomly choosing fifteen muscle cells from the total number of fibers
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in each sample by using the random integer generator tool ascertained from
Random.org.47
The dependent variables of nuclear content per muscle fiber, total muscle crosssectional area, number of fibers per area of muscle, and proportion of type I and type II
fibers were analyzed by comparing the descriptive statistics of means and ratios.
Inferences were made from the muscle fiber area variable in terms of the entire genotype
population through the aforementioned randomization procedure. The independent
variable for all of these areas was the differing genotype (Ames dwarf vs wild-type).

11

CHAPTER III
RESULTS
Muscle Fiber Size
An independent-measures T-test revealed a statistically significant difference in
muscle fiber size of the soleus muscle between the Ames dwarf and wild type mice
(t(58)=-9.71, p<.001) with the normal mice demonstrating significantly larger muscle
fibers (M=1973.9 square micrometers) than the Ames dwarf mice (M=770.3 square
micrometers (see Figure 2 and Table 1).

*

Figure 2. Mean Cross-sectional Area of Muscle Fiber by Genotype.
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Table 1. Mean Cross-sectional Area of Muscle Fiber by Specimen and Genotype.
Ames Dwarf 1
165
Number of muscle
fibers
Mean fiber area
877.1
2
(µm )
Mean fiber area by
Genotype (µm2)
* = significant difference p<.05

Ames Dwarf 2

Wild-type 1

Wild-type 2

273

438

395

721.9

2084.1

2086.2

770.3*

1973.9*

Type I and Type II Muscle Fibers
Descriptive analysis of the number of type I muscle fibers revealed that the Ames
dwarf mouse had an average of 86% more type I than type II muscle fibers in the soleus
muscle, including one specimen that had 132% more type I fibers (2:1 ratio of type I to
type II muscle fibers for both dwarf specimens combined). In striking contrast to these
results, the normal mice averaged only 4% more type I than type II fibers in their soleus
muscles (essentially a 1:1 ratio of type I to type II muscle fibers for both wild-type
specimens combined). (See Table 2, and Figures 3, 4, and 5). Due to the limited number
of mice available for this study, statistical analyses were not performed and this data is
presented in a strictly descriptive capacity.
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Table 2. Number of Soleus Muscle Fiber Type by Specimen
Ames Dwarf 1

Ames Dwarf 2

Wild-type 1

Wild-type 2

Type I fibers

220

388

272

195

Type II fibers

133

167

253

196

Fast-twitch
Type II FibersFibers
Type I Fibers Fibers
Slow-twitch
500

Number of fiber type

400

300

200

100

0
1

2

Dwarf
Dwarf 1I

3

4

5

Dwarf II2
Dwarf

6

Normal 1 I
Wild‐type

Figure 3. Number of Type I and Type II Fibers by Genotype.
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7

8

Normal
Wild
Type2 II

Figure 4. Type I Stain of Ames Dwarf Soleus.
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Figure 5. Type I Stain of Wild-type Soleus.
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Myonuclear Content
Descriptive analysis of the myonuclear content per muscle fiber revealed values
of 2.25 and 2.01 for the Ames dwarf mice soleus muscles and values of 2.45 and 3.88 for
the wild-type mice soleus muscles (see Figure 6). A calculation of the differences of
these means show that the wild-type mice averaged 1.035 more nuclei in each muscle
fiber. Due to the limited number of mice available for this study, statistical analyses were
not performed and this data is presented in a strictly descriptive capacity.

Table 3. Number of Myonuclei by Specimen

Number of
Myonuclei

Ames Dwarf 1

Ames Dwarf 2

Wild-type 1

Wild-type 2

371

548

1,073

1,532
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Myonuclei per muscle fiber

5

4

3

2

1

0

Dwarf
Dwarf I1

Normal 1I
Wild‐type

Dwarf
Dwarf II2

Normal
Wild
Type2II

Figure 6. Mean Myonuclei per Muscle Fiber by Genotype.

Cross-sectional Area
The data comparing the cross-sectional areas of the soleus muscles are
substantially confounded by the limitation in size of the viewable sample. The soleus
muscles of both wild-type mouse specimens were too large to fit in the microscope
camera window at 10x magnification, and thus the entire muscle was not fully available
for cellular analysis. However, the Ames dwarf soleus was small enough to be fully
viewed at this microscopic magnification with size results of 177,788.8 and 253,935.9
square micrometers, respectively. For relative comparison, the incomplete views of the
wild-type mouse soleus muscles had sizes of 1,142,092 and 1,045,274.1 square
micrometers, respectively. Thus, the size difference between the wild-type and Ames
18

dwarf mouse becomes clearly evident as a partial view of the wild-type mouse soleus is
an average of 5.06 times larger than an Ames dwarf soleus. (See Figures 7 and 8 for
views of the wild-type soleus and dwarf soleus, respectively).

Figure 7. Hematoxylin and Eosin Stain of Ames Dwarf Soleus.
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Figure 8. Hematoxylin and Eosin Stain of Wild-type Soleus.
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CHAPTER IV
DISCUSSION
The results for the variables of muscle fiber size and muscle cross-sectional area
were as expected based on the relative size difference between the two genotypes with
the wild-type mouse soleus displaying significantly larger size fibers (average of 2.56
times larger) and cross-sectional area (average of 5.06 times larger) than the dwarf mouse
soleus. This cross-sectional area size difference is greater than would be expected, as it
has previously been reported that the Ames dwarf mouse is one-third the size of a wildtype mouse.39 This cross-sectional area difference is not entirely accurate and would
actually be greater as the entirety of the wild-type soleus muscle was too large to fit into
the 10 times magnified microscopic image as is discussed below.
The descriptive results for myonuclear content per muscle fiber reveal a slightly
higher number of myonuclei per muscle fiber in the wild-type mice than the dwarf mice,
which may indicate that although myonuclei are beneficial in muscle protein production,
they may not contribute to, and in fact may negatively contribute to longevity. However,
one advantage that the wild-type mice gain by having a greater number of myonuclei is
that these mice would be able to more quickly adapt to stresses (injury, exercise, disease)
placed on the muscle than the Ames dwarf mice, as myonuclei number has been
associated with increased skeletal muscle adaptations.48 Previous studies have shown
that myonuclei number and size change with age in mice, and that these changes may
21

contribute to the gross muscle strength decline and sarcopenia that is associated with
aging.49 Future studies should analyze the myonuclear content of the Ames dwarf and
wild-type mice of differing ages to determine if these results are consistent or altered in
any manner.
The most striking results obtained from this study were the differences found in
the number of type I and type II muscle fiber types between the Ames dwarf and wildtype mice. The Ames dwarf mice were found to have 86% more type I than type II fibers
in their soleus muscles compared with 4% more type I fibers in the wild-type soleus
muscles. Both the Ames dwarf and wild-type results differ from previous studies that
have found the soleus muscles of rats to be composed of 90% slow-twitch fibers.33 This
difference may be a result of the function of the soleus muscle between these species,
with potentially greater anaerobic activities utilized in the Ames dwarf and wild-type
soleus than in the rat soleus.
The dramatic increase in type I fibers exhibited in the Ames dwarf compared to
the wild-type mice may be a reason that both the Ames dwarf’s active and resting skeletal
muscle have been found to demonstrate heightened antioxidant defenses compared to
wild-type mice.45 Our results support the findings and conclusions of this study, as Type I
muscle fibers have been shown to demonstrate less susceptibility to oxidative damage,37
and that the elevated levels of Type I fibers demonstrated in this study could contribute to
the decelerated aging demonstrated by the Ames dwarf.39
This study had several limitations and considerations for future research. The
most significant limitation encountered was the time constraints placed upon the
22

completion of this study. This lack of time resulted in the limited number of samples that
were dissected and analyzed, which in turn resulted in a small number of degrees of
freedom in our calculations which makes significant results and distinct conclusions
difficult to achieve. This small number of samples was partially rectified by the
randomization procedure to create a larger sample from our population of cell counts, but
this situation is not ideal. In future studies, a greater number of mice creating a larger
pool of samples should be utilized. Also, since this study only evaluated the soleus
muscles of these genotypes, a wider variety of muscles should be studied (gastrocnemius,
tibialis anterior, EDL) in the future to see if the results of the current study apply to
muscles that may be composed differently than the soleus.
Another important limitation of this study was that only one age group of mice (3months old) was analyzed. For more thorough conclusions, different age ranges of each
genotype should be studied to see if the results found in the current study persist
throughout the lifespan of these mice. These future results can then be interpreted in
relation to sarcopenia and age-related changes in muscle function secondary to potential
effects of resistance to aging in the Ames dwarf mice.
An additional limitation experienced during this study was the insufficient
microscopic views of our tissue samples. All of our samples were analyzed at a
magnification of 10x, which provided adequate detail for our methodology, but did not
provide a full view of the entire cross-sectional area of the wild-type soleus muscle (see
Figures 5 & 8). This incomplete view did not allow for a full analysis of number of cells
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and fiber types present throughout the entire area of the muscle. Future studies should
consider appropriate methodology to account for this problem.
The last limitation to consider would be potential human error and bias during
fiber size measurements. Although human error as a confounding variable was addressed
through taking an average of three measurements for each fiber size, bias was not
addressed. The researchers were not blinded during measurements or analysis of cell size
or fiber type. This lack of blinding could have led to smaller measurements for the dwarf
mice fiber size, or larger measurements for the wild-type fiber size, thus leading to
incorrect data. Although blinding may not be possible due to the noticeable size
difference between the tissue samples from each genotype (see Figures 7 & 8), future
studies should take this issue into consideration.
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